Abstract：
UNASSIGNED: The ubiquity of social media has ushered in an era where uncontrolled content sharing extends to all subjects, including sensitive topics such as medication consumption.
UNASSIGNED: To quantify the prevalence of YouTube videos providing information on glucocorticoids and to underscore the risks associated with inaccurate information, which might inadvertently promote inappropriate use of these medications.
UNASSIGNED: The YouTube videos were selected using predefined keywords from February 20 to March 4, 2023. The videos were categorized into two groups. Category 1 promotes the misuse of corticosteroids, while Category 2 raises awareness about the risks associated with these drugs.
UNASSIGNED: In total, 843 YouTube videos were included. Approximately 76% of the creators were women. Of these, category 1 videos (69.63%) predominated over Category 2 videos (30.37%). Regarding Category 1, dexamethasone was mentioned in 41.53% of cases, followed by hydrocortisone (17.30%). According to these YouTubers, these products/medications are mainly obtained from community pharmacies (58.09%), online shops (20.01%), and through illicit markets and the black market (13.46%). Weight gain was the most common objective, according to 32.62% of the YouTubers.
UNASSIGNED: This study highlights the prevalence of YouTube videos regarding the misuse of corticosteroids. The common focus on weight gain as an objective underscores the importance of educating content creators and viewers about responsible corticosteroid use. Targeted interventions are needed to promote safe and informed medication practices within this online environment.
UNASSIGNED: To quantify the prevalence of YouTube videos providing information on glucocorticoids and to underscore the risks associated with inaccurate information, which might inadvertently promote inappropriate use of these medications.
UNASSIGNED: The YouTube videos were selected using predefined keywords from February 20 to March 4, 2023. The videos were categorized into two groups. Category 1 promotes the misuse of corticosteroids, while Category 2 raises awareness about the risks associated with these drugs.
UNASSIGNED: In total, 843 YouTube videos were included. Approximately 76% of the creators were women. Of these, category 1 videos (69.63%) predominated over Category 2 videos (30.37%). Regarding Category 1, dexamethasone was mentioned in 41.53% of cases, followed by hydrocortisone (17.30%). According to these YouTubers, these products/medications are mainly obtained from community pharmacies (58.09%), online shops (20.01%), and through illicit markets and the black market (13.46%). Weight gain was the most common objective, according to 32.62% of the YouTubers.
UNASSIGNED: This study highlights the prevalence of YouTube videos regarding the misuse of corticosteroids. The common focus on weight gain as an objective underscores the importance of educating content creators and viewers about responsible corticosteroid use. Targeted interventions are needed to promote safe and informed medication practices within this online environment.
摘要：
■社交媒体的无处不在开创了一个不受控制的内容共享扩展到所有主题的时代，包括药物消费等敏感话题。
为了量化提供糖皮质激素信息的YouTube视频的患病率，并强调与不准确信息相关的风险，这可能会无意中促进这些药物的不当使用。
■YouTube视频是使用2月20日至2023年3月4日的预定义关键字选择的。这些视频分为两组。第1类促进皮质类固醇的滥用，而第2类提高了对这些药物相关风险的认识。
■总共，包括843个YouTube视频。大约76%的创作者是女性。其中,第一类视频（69.63%）比第二类视频（30.37%）占优势。关于1类，在41.53%的病例中提到了地塞米松，其次是氢化可的松(17.30%)。根据这些YouTubers的说法,这些产品/药物主要来自社区药房(58.09%)，网上商店（20.01%），以及非法市场和黑市(13.46%)。体重增加是最常见的目标，根据32.62%的YouTubers。
■这项研究突出了YouTube视频中关于皮质类固醇滥用的流行情况。以体重增加为目标的共同关注强调了教育内容创建者和观看者有关负责任的皮质类固醇使用的重要性。需要有针对性的干预措施，以在这种在线环境中促进安全和知情的用药实践。
为了量化提供糖皮质激素信息的YouTube视频的患病率，并强调与不准确信息相关的风险，这可能会无意中促进这些药物的不当使用。
■YouTube视频是使用2月20日至2023年3月4日的预定义关键字选择的。这些视频分为两组。第1类促进皮质类固醇的滥用，而第2类提高了对这些药物相关风险的认识。
■总共，包括843个YouTube视频。大约76%的创作者是女性。其中,第一类视频（69.63%）比第二类视频（30.37%）占优势。关于1类，在41.53%的病例中提到了地塞米松，其次是氢化可的松(17.30%)。根据这些YouTubers的说法,这些产品/药物主要来自社区药房(58.09%)，网上商店（20.01%），以及非法市场和黑市(13.46%)。体重增加是最常见的目标，根据32.62%的YouTubers。
■这项研究突出了YouTube视频中关于皮质类固醇滥用的流行情况。以体重增加为目标的共同关注强调了教育内容创建者和观看者有关负责任的皮质类固醇使用的重要性。需要有针对性的干预措施，以在这种在线环境中促进安全和知情的用药实践。
